Chimerix Announces Initiation of a Phase 2/3 Study of DSTAT in Acute Lung Injury for Patients with Severe COVID-19

    NEXT STORY
    TG Therapeutics Bolsters Board of Directors with the Appointment of Sagar Lonial, MD
    PREV STORY
    Teleflex to Present at the Bank of America Merrill Lynch 2020 Health Care Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Novartis delivered strong sales growth, margin expansion and breakthrough innovation launching five NMEs in 2019

    author_avatar
    NASDAQ Market News

    Melinta Therapeutics Provides Corporate Updates

    ~ Highlights Continued Positive Sales Momentum and Estimated Year-End Cash Position ~ ~ Confirms ...

    author_avatar
    NASDAQ Market News

    Precision Therapeutics Receives Approval of Delisting Request from German Stock Exchange

    MINNEAPOLIS, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or ...

    author_avatar
    NASDAQ Market News